30 0 2 0 2 B-lower_bound
to 3 5 3 5 O
80 6 8 6 8 B-upper_bound
years 9 14 9 14 I-upper_bound
of 15 17 15 17 O
age 18 21 18 21 B-age
on 22 24 22 24 O
the 25 28 25 28 O
date 29 33 29 33 O
of 34 36 34 36 O
informed 37 45 37 45 O
consent 46 53 46 53 O

At 0 2 54 56 O
the 3 6 57 60 O
time 7 11 61 65 O
of 12 14 66 68 O
the 15 18 69 72 O
biopsy 19 25 73 79 B-treatment
and 26 29 80 83 I-treatment
injections 30 40 84 94 I-treatment
, 40 41 94 95 O
the 42 45 96 99 O
subject 46 53 100 107 O
's 53 55 107 109 O
BP 56 58 110 112 O
should 59 65 113 119 O
notbe 66 71 120 125 O
significantly 72 85 126 139 O
below 86 91 140 145 O
the 92 95 146 149 O
previously 96 106 150 160 O
recorded 107 115 161 169 O
stable 116 122 170 176 O
pressure 123 131 177 185 O

Dose 0 4 186 190 O
interruptions 5 18 191 204 O
up 19 21 205 207 O
to 22 24 208 210 O
7 25 26 211 212 B-upper_bound
days 27 31 213 217 I-upper_bound
due 32 35 218 221 O
to 36 38 222 224 O
medical 39 46 225 232 O
necessity 47 56 233 242 O
are 57 60 243 246 O
allowed 61 68 247 254 O

Stable 0 6 255 261 O
treatment 7 16 262 271 B-treatment
is 17 19 272 274 O
defined 20 27 275 282 O
as 28 30 283 285 O
dose 31 35 286 290 O
adjustment 36 46 291 301 O
to 47 49 302 304 O
no 50 52 305 307 O
less 53 57 308 312 O
than 58 62 313 317 O
one 63 66 318 321 B-upper_bound
half 67 71 322 326 I-upper_bound
of 72 74 327 329 O
the 75 78 330 333 O
current 79 86 334 341 O
dosage 87 93 342 348 O
or 94 96 349 351 O
to 97 99 352 354 O
no 100 102 355 357 O
more 103 107 358 362 O
than 108 112 363 367 O
2 113 114 368 369 B-upper_bound
times 115 120 370 375 I-upper_bound
the 121 124 376 379 O
current 125 132 380 387 O
dosage 133 139 388 394 O

The 0 3 395 398 O
subject 4 11 399 406 O
should 12 18 407 413 O
have 19 23 414 418 O
adequate 24 32 419 427 O
, 32 33 427 428 O
historical 34 44 429 439 O
clinical 45 53 440 448 O
data 54 58 449 453 O
to 59 61 454 456 O
provide 62 69 457 464 O
a 70 71 465 466 O
reasonable 72 82 467 477 O
estimate 83 91 478 486 O
of 92 94 487 489 O
the 95 98 490 493 O
rate 99 103 494 498 O
of 104 106 499 501 O
progression 107 118 502 513 O
of 119 121 514 516 O
CKD 122 125 517 520 B-chronic_disease

Treatment 0 9 521 530 B-treatment
must 10 14 531 535 O
be 15 17 536 538 O
stable 18 24 539 545 O
during 25 31 546 552 O
the 32 35 553 556 O
6 36 37 557 558 B-upper_bound
- 37 38 558 559 I-upper_bound
week 38 42 559 563 I-upper_bound
period 43 49 564 570 O
immediately 50 61 571 582 O
prior 62 67 583 588 O
to 68 70 589 591 O
NKA 71 74 592 595 B-treatment
injection 75 84 596 605 I-treatment

acute 0 5 606 611 B-chronic_disease
kidney 6 12 612 618 I-chronic_disease
injury 13 19 619 625 I-chronic_disease
or 20 22 626 628 O
has 23 26 629 632 O
experienced 27 38 633 644 O
a 39 40 645 646 O
rapid 41 46 647 652 O
decline 47 54 653 660 O
in 55 57 661 663 O
renal 58 63 664 669 B-chronic_disease
function 64 72 670 678 I-chronic_disease
during 73 79 679 685 O
the 80 83 686 689 O
last 84 88 690 694 B-upper_bound
3 89 90 695 696 I-upper_bound
months 91 97 697 703 I-upper_bound
prior 98 103 704 709 I-upper_bound
to 104 106 710 712 O
NKA 107 110 713 716 B-treatment
injection 111 120 717 726 I-treatment

anatomic 0 8 727 735 O
abnormalities 9 22 736 749 O
that 23 27 750 754 O
would 28 33 755 760 O
interfere 34 43 761 770 O
with 44 48 771 775 O
the 49 52 776 779 O
NKA 53 56 780 783 B-treatment
injection 57 66 784 793 I-treatment
procedure 67 76 794 803 O

any 0 3 804 807 O
contraindication 4 20 808 824 O
to 21 23 825 827 O
local 24 29 828 833 B-allergy_name
anesthetics 30 41 834 845 I-allergy_name
or 42 44 846 848 O
sedatives 45 54 849 858 B-allergy_name

blood 0 5 859 864 B-clinical_variable
pressure 6 14 865 873 I-clinical_variable
less 15 19 874 878 O
than 20 24 879 883 O
150/90 25 31 884 890 B-upper_bound
at 32 34 891 893 O
the 35 38 894 897 O
Screening 39 48 898 907 O
Visit 49 54 908 913 O
, 54 55 913 914 O
prior 56 61 915 920 O
to 62 64 921 923 O
renal 65 70 924 929 B-treatment
biopsy 71 77 930 936 I-treatment
, 77 78 936 937 O
and 79 82 938 941 O
prior 83 88 942 947 O
to 89 91 948 950 O
NKA 92 95 951 954 B-treatment
injection(s 96 107 955 966 I-treatment
) 107 108 966 967 I-treatment

clinically 0 10 968 978 O
significant 11 22 979 990 O
hepatic 23 30 991 998 B-chronic_disease
disease 31 38 999 1006 I-chronic_disease
( 39 40 1007 1008 O
ALT 40 43 1008 1011 B-clinical_variable
or 44 46 1012 1014 O
AST 47 50 1015 1018 B-clinical_variable
greater 51 58 1019 1026 O
than 59 63 1027 1031 O
3 64 65 1032 1033 B-lower_bound
- 65 66 1033 1034 I-lower_bound
times 66 71 1034 1039 I-lower_bound
the 72 75 1040 1043 I-lower_bound
upper 76 81 1044 1049 I-lower_bound
limit 82 87 1050 1055 I-lower_bound
of 88 90 1056 1058 I-lower_bound
normal 91 97 1059 1065 I-lower_bound
) 97 98 1065 1066 O
as 99 101 1067 1069 O
assessed 102 110 1070 1078 O
at 111 113 1079 1081 O
the 114 117 1082 1085 O
Screening 118 127 1086 1095 O
Visit 128 133 1096 1101 O

established 0 11 1102 1113 O
diagnosis 12 21 1114 1123 O
of 22 24 1124 1126 O
CKD 25 28 1127 1130 B-chronic_disease
not 29 32 1131 1134 O
requiring 33 42 1135 1144 O
renal 43 48 1145 1150 B-treatment
dialysis 49 57 1151 1159 I-treatment
, 57 58 1159 1160 O
defined 59 66 1161 1168 O
as 67 69 1169 1171 O
having 70 76 1172 1178 O
an 77 79 1179 1181 O
eGFR 80 84 1182 1186 B-clinical_variable
between 85 92 1187 1194 O
20 93 95 1195 1197 B-lower_bound
and 96 99 1198 1201 O
50 100 102 1202 1204 B-upper_bound
mL 103 105 1205 1207 I-upper_bound
/ 105 106 1207 1208 I-upper_bound
min/1.73m2 106 116 1208 1218 I-upper_bound
inclusive 117 126 1219 1228 O
at 127 129 1229 1231 O
the 130 133 1232 1235 O
Screening 134 143 1236 1245 O
Visit 144 149 1246 1251 O
and 150 153 1252 1255 O
prior 154 159 1256 1261 O
to 160 162 1262 1264 O
NKA 163 166 1265 1268 O
injection 167 176 1269 1278 O

established 0 11 1279 1290 O
diagnosis 12 21 1291 1300 O
of 22 24 1301 1303 O
diabetic 25 33 1304 1312 B-chronic_disease
nephropathy 34 45 1313 1324 I-chronic_disease
as 46 48 1325 1327 O
the 49 52 1328 1331 O
underlying 53 63 1332 1342 O
cause 64 69 1343 1348 O
of 70 72 1349 1351 O
renal 73 78 1352 1357 B-chronic_disease
disease 79 86 1358 1365 I-chronic_disease

evidence 0 8 1366 1374 O
of 9 11 1375 1377 O
a 12 13 1378 1379 O
urinary 14 21 1380 1387 B-chronic_disease
tract 22 27 1388 1393 I-chronic_disease
infection 28 37 1394 1403 I-chronic_disease

female 0 6 1404 1410 B-gender

female 0 6 1411 1417 B-gender
subject 7 14 1418 1425 I-gender

female 0 6 1426 1432 B-gender
subject 7 14 1433 1440 I-gender
is 15 17 1441 1443 O
of 18 20 1444 1446 O
child 21 26 1447 1452 O
- 26 27 1452 1453 O
bearing 27 34 1453 1460 O
potential 35 44 1461 1470 O
and 45 48 1471 1474 O
is 49 51 1475 1477 O
not 52 55 1478 1481 O
using 56 61 1482 1487 O
a 62 63 1488 1489 O
highly 64 70 1490 1496 O
effective 71 80 1497 1506 O
method(s 81 89 1507 1515 O
) 89 90 1515 1516 O
of 91 93 1517 1519 O
birth 94 99 1520 1525 O
control 100 107 1526 1533 O
, 107 108 1533 1534 O
including 109 118 1535 1544 O
sexual 119 125 1545 1551 O
abstinence 126 136 1552 1562 O

female 0 6 1563 1569 B-gender
subject 7 14 1570 1577 I-gender
is 15 17 1578 1580 O
unwilling 18 27 1581 1590 B-contraception_consent
to 28 30 1591 1593 I-contraception_consent
continue 31 39 1594 1602 I-contraception_consent
using 40 45 1603 1608 I-contraception_consent
a 46 47 1609 1610 I-contraception_consent
highly 48 54 1611 1617 I-contraception_consent
- 54 55 1617 1618 I-contraception_consent
effective 55 64 1618 1627 I-contraception_consent
method 65 71 1628 1634 I-contraception_consent
of 72 74 1635 1637 I-contraception_consent
birth 75 80 1638 1643 I-contraception_consent
control 81 88 1644 1651 I-contraception_consent
throughout 89 99 1652 1662 O
the 100 103 1663 1666 O
duration 104 112 1667 1675 O
of 113 115 1676 1678 O
the 116 119 1679 1682 O
study 120 125 1683 1688 O

history 0 7 1689 1696 O
of 8 10 1697 1699 O
active 11 17 1700 1706 O
tuberculosis 18 30 1707 1719 B-chronic_disease
( 31 32 1720 1721 I-chronic_disease
TB 32 34 1721 1723 I-chronic_disease
) 34 35 1723 1724 I-chronic_disease
requiring 36 45 1725 1734 O
treatment 46 55 1735 1744 B-treatment
within 56 62 1745 1751 O
the 63 66 1752 1755 O
past 67 71 1756 1760 B-upper_bound
3 72 73 1761 1762 I-upper_bound
years 74 79 1763 1768 I-upper_bound

history 0 7 1769 1776 O
of 8 10 1777 1779 O
anaphylactic 11 23 1780 1792 O
or 24 26 1793 1795 O
severe 27 33 1796 1802 O
systemic 34 42 1803 1811 O
reaction(s 43 53 1812 1822 O
) 53 54 1822 1823 O
or 55 57 1824 1826 O
contraindication(s 58 76 1827 1845 O
) 76 77 1845 1846 O
to 78 80 1847 1849 O
human 81 86 1850 1855 B-allergy_name
blood 87 92 1856 1861 I-allergy_name
products 93 101 1862 1870 I-allergy_name
or 102 104 1871 1873 O
materials 105 114 1874 1883 O
of 115 117 1884 1886 O
animal 118 124 1887 1893 O
origin 125 131 1894 1900 O
( 132 133 1901 1902 O
eg 133 135 1902 1904 O
, 135 136 1904 1905 O
bovine 137 143 1906 1912 B-allergy_name
, 143 144 1912 1913 O
porcine 145 152 1914 1921 B-allergy_name
) 152 153 1921 1922 O

history 0 7 1923 1930 O
of 8 10 1931 1933 O
cancer 11 17 1934 1940 B-cancer
within 18 24 1941 1947 O
the 25 28 1948 1951 O
past 29 33 1952 1956 B-upper_bound
3 34 35 1957 1958 I-upper_bound
years 36 41 1959 1964 I-upper_bound

history 0 7 1965 1972 O
of 8 10 1973 1975 O
severe 11 17 1976 1982 O
systemic 18 26 1983 1991 B-chronic_disease
reaction(s 27 37 1992 2002 I-chronic_disease
) 37 38 2002 2003 I-chronic_disease

immunocompromised 0 17 2004 2021 O
or 18 20 2022 2024 O
is 21 23 2025 2027 O
receiving 24 33 2028 2037 O
immunosuppressive 34 51 2038 2055 B-treatment
agents 52 58 2056 2062 I-treatment
, 58 59 2062 2063 O
including 60 69 2064 2073 O
individuals 70 81 2074 2085 O
treated 82 89 2086 2093 O
for 90 93 2094 2097 O
chronic 94 101 2098 2105 B-chronic_disease
glomerulonephritis 102 120 2106 2124 I-chronic_disease
within 121 127 2125 2131 O
3 128 129 2132 2133 B-upper_bound
months 130 136 2134 2140 I-upper_bound
of 137 139 2141 2143 O
NKA 140 143 2144 2147 B-treatment
injection 144 153 2148 2157 I-treatment

incapacitating 0 14 2158 2172 B-chronic_disease
cardiac 15 22 2173 2180 I-chronic_disease
and/or 23 29 2181 2187 O
pulmonary 30 39 2188 2197 B-chronic_disease
disorders 40 49 2198 2207 I-chronic_disease

individuals 0 11 2208 2219 O
who 12 15 2220 2223 O
are 16 19 2224 2227 O
morbidly 20 28 2228 2236 B-chronic_disease
obese 29 34 2237 2242 I-chronic_disease
( 35 36 2243 2244 O
defined 36 43 2244 2251 O
as 44 46 2252 2254 O
BMI 47 50 2255 2258 B-bmi
greater 51 58 2259 2266 O
than 59 63 2267 2271 O
45 64 66 2272 2274 B-lower_bound
kg 67 69 2275 2277 I-lower_bound
/ 69 70 2277 2278 I-lower_bound
m2 70 72 2278 2280 I-lower_bound
) 72 73 2280 2281 O
, 73 74 2281 2282 O
have 75 79 2283 2287 O
excessive 80 89 2288 2297 O
fat 90 93 2298 2301 O
surrounding 94 105 2302 2313 O
the 106 109 2314 2317 O
kidney 110 116 2318 2324 O
, 116 117 2324 2325 O
or 118 120 2326 2328 O
who 121 124 2329 2332 O
are 125 128 2333 2336 O
otherwise 129 138 2337 2346 O
at 139 141 2347 2349 O
excessive 142 151 2350 2359 O
risk 152 156 2360 2364 O
for 157 160 2365 2368 O
serious 161 168 2369 2376 O
complications 169 182 2377 2390 O

inhaled 0 7 2391 2398 B-treatment
corticosteroids 8 23 2399 2414 I-treatment
and 24 27 2415 2418 O
chronic 28 35 2419 2426 B-treatment
low 36 39 2427 2430 I-treatment
- 39 40 2430 2431 I-treatment
dose 40 44 2431 2435 I-treatment
corticosteroids 45 60 2436 2451 I-treatment
( 61 62 2452 2453 O
less 62 66 2453 2457 O
than 67 71 2458 2462 O
or 72 74 2463 2465 O
equal 75 80 2466 2471 O
to 81 83 2472 2474 O
7.5 84 87 2475 2478 B-upper_bound
mg 88 90 2479 2481 I-upper_bound
per 91 94 2482 2485 I-upper_bound
day 95 98 2486 2489 I-upper_bound
) 98 99 2489 2490 O
are 100 103 2491 2494 O
permitted 104 113 2495 2504 O
as 114 116 2505 2507 O
are 117 120 2508 2511 O
brief 121 126 2512 2517 O
pulsed 127 133 2518 2524 O
corticosteroids 134 149 2525 2540 O
for 150 153 2541 2544 O
intermittent 154 166 2545 2557 O
symptoms 167 175 2558 2566 O
( 176 177 2567 2568 O
eg 177 179 2568 2570 O
, 179 180 2570 2571 O
asthma 181 187 2572 2578 B-chronic_disease
) 187 188 2578 2579 O

life 0 4 2580 2584 B-clinical_variable
expectancy 5 15 2585 2595 I-clinical_variable
less 16 20 2596 2600 O
than 21 25 2601 2605 O
2 26 27 2606 2607 B-upper_bound
years 28 33 2608 2613 I-upper_bound

male 0 4 2614 2618 B-gender

non 0 3 2619 2622 B-cancer
- 3 4 2622 2623 I-cancer
melanoma 4 12 2623 2631 I-cancer
skin 13 17 2632 2636 I-cancer
cancer 18 24 2637 2643 I-cancer
and 25 28 2644 2647 O
carcinoma 29 38 2648 2657 B-cancer
in 39 41 2658 2660 I-cancer
situ 42 46 2661 2665 I-cancer
of 47 49 2666 2668 I-cancer
the 50 53 2669 2672 I-cancer
cervix 54 60 2673 2679 I-cancer

planning 0 8 2680 2688 B-pregnancy
a 9 10 2689 2690 I-pregnancy
pregnancy 11 20 2691 2700 I-pregnancy
during 21 27 2701 2707 O
the 28 31 2708 2711 O
course 32 38 2712 2718 O
of 39 41 2719 2721 O
the 42 45 2722 2725 O
study 46 51 2726 2731 O

polycystic 0 10 2732 2742 B-chronic_disease
kidney 11 17 2743 2749 I-chronic_disease
disease 18 25 2750 2757 I-chronic_disease

positive 0 8 2758 2766 O
for 9 12 2767 2770 O
active 13 19 2771 2777 B-chronic_disease
infection 20 29 2778 2787 I-chronic_disease
with 30 34 2788 2792 O
Hepatitis 35 44 2793 2802 B-chronic_disease
B 45 46 2803 2804 I-chronic_disease
Virus 47 52 2805 2810 I-chronic_disease
( 53 54 2811 2812 I-chronic_disease
HBV 54 57 2812 2815 I-chronic_disease
) 57 58 2815 2816 I-chronic_disease
, 58 59 2816 2817 O
or 60 62 2818 2820 O
Hepatitis 63 72 2821 2830 B-chronic_disease
C 73 74 2831 2832 I-chronic_disease
Virus 75 80 2833 2838 I-chronic_disease
( 81 82 2839 2840 I-chronic_disease
HCV 82 85 2840 2843 I-chronic_disease
) 85 86 2843 2844 I-chronic_disease
, 86 87 2844 2845 O
and/or 88 94 2846 2852 O
Human 95 100 2853 2858 B-chronic_disease
Immunodeficiency 101 117 2859 2875 I-chronic_disease
Virus 118 123 2876 2881 I-chronic_disease
( 124 125 2882 2883 I-chronic_disease
HIV 125 128 2883 2886 I-chronic_disease
) 128 129 2886 2887 I-chronic_disease
as 130 132 2888 2890 O
assessed 133 141 2891 2899 O
at 142 144 2900 2902 O
the 145 148 2903 2906 O
Screening 149 158 2907 2916 O
Visit 159 164 2917 2922 O

renal 0 5 2923 2928 B-cancer
tumors 6 12 2929 2935 I-cancer

serum 0 5 2936 2941 B-clinical_variable
HbA1c 6 11 2942 2947 I-clinical_variable
level 12 17 2948 2953 I-clinical_variable
greater 18 25 2954 2961 O
than 26 30 2962 2966 O
10 31 33 2967 2969 B-lower_bound
% 33 34 2969 2970 I-lower_bound
at 35 37 2971 2973 O
the 38 41 2974 2977 O
Screening 42 51 2978 2987 O
Visit 52 57 2988 2993 O

subject 0 7 2994 3001 O
is 8 10 3002 3004 O
not 11 14 3005 3008 O
a 15 16 3009 3010 O
good 17 21 3011 3015 O
candidate 22 31 3016 3025 O
to 32 34 3026 3028 O
undergo 35 42 3029 3036 O
percutaneous 43 55 3037 3049 B-treatment
NKA 56 59 3050 3053 I-treatment
injection 60 69 3054 3063 I-treatment
, 69 70 3063 3064 O
in 71 73 3065 3067 O
the 74 77 3068 3071 O
judgment 78 86 3072 3080 O
of 87 89 3081 3083 O
the 90 93 3084 3087 O
surgeon 94 101 3088 3095 O
or 102 104 3096 3098 O
physician 105 114 3099 3108 O
who 115 118 3109 3112 O
will 119 123 3113 3117 O
perform 124 131 3118 3125 O
the 132 135 3126 3129 O
procedure 136 145 3130 3139 O

uncontrolled 0 12 3140 3152 O
diabetes 13 21 3153 3161 B-chronic_disease
( 22 23 3162 3163 O
defined 23 30 3163 3170 O
as 31 33 3171 3173 O
metabolically 34 47 3174 3187 O
unstable 48 56 3188 3196 O
by 57 59 3197 3199 O
the 60 63 3200 3203 O
Investigator 64 76 3204 3216 O
) 76 77 3216 3217 O

willing 0 7 3218 3225 O
and 8 11 3226 3229 O
able 12 16 3230 3234 O
to 17 19 3235 3237 O
refrain 20 27 3238 3245 O
from 28 32 3246 3250 O
NSAID 33 38 3251 3256 B-treatment
consumption 39 50 3257 3268 O
( 51 52 3269 3270 O
including 52 61 3270 3279 O
aspirin 62 69 3280 3287 B-treatment
) 69 70 3287 3288 O
as 71 73 3289 3291 O
well 74 78 3292 3296 O
as 79 81 3297 3299 O
clopidogrel 82 93 3300 3311 B-treatment
, 93 94 3311 3312 O
prasugrel 95 104 3313 3322 B-treatment
, 104 105 3322 3323 O
or 106 108 3324 3326 O
other 109 114 3327 3332 O
platelet 115 123 3333 3341 O
inhibitors 124 134 3342 3352 O
during 135 141 3353 3359 O
the 142 145 3360 3363 O
period 146 152 3364 3370 O
beginning 153 162 3371 3380 O
7 163 164 3381 3382 O
days 165 169 3383 3387 O
before 170 176 3388 3394 O
through 177 184 3395 3402 O
7 185 186 3403 3404 O
days 187 191 3405 3409 O
after 192 197 3410 3415 O
both 198 202 3416 3420 O
the 203 206 3421 3424 O
renal 207 212 3425 3430 B-treatment
biopsy 213 219 3431 3437 I-treatment
and 220 223 3438 3441 O
NKA 224 227 3442 3445 B-treatment
injection(s 228 239 3446 3457 I-treatment
) 239 240 3457 3458 I-treatment

